The threshold at which tirzepatide meaningfully reduces food intake rises as your body acclimates
PlexusDx uses the Precision Peptide Genetic Test to identify your predispositions in peptide genetic pathways, revealing whether genetic variants in GLP1R, GIPR, FTO, and MC4R genes influence your likelihood of responding optimally to tirzepatide therapy
People with diabetes are at risk for not only diabetic retinopathy but also the development of conditions, such as cataracts, glaucoma and dry eye
Because each peptide acts on a different node of the same shared pathways (the VEGF axis, NF-kB suppression, ECM remodeling), the combination is theoretically additive rather than redundant
The SUSTAIN and STEP trial programs for semaglutide, involving thousands of participants followed for up to two years, did not demonstrate an increased overall cancer risk compared to placebo groups